Roboclinic Tirzepatide Review: Cost, an AI-First Intake & Honest Verdict (2026)

Roboclinic is an AI-first telehealth platform, operated by BrickFi, Inc., that starts you with an AI health assistant and then routes you to a board-certified provider for GLP-1 weight-loss care — a genuinely different intake model from most providers here. Every fact here comes from the company's own published program.

What Roboclinic is

Roboclinic is an AI-first telehealth platform, offering compounded semaglutide and tirzepatide with "same price, every dose" — your cost doesn't rise as the dose increases. It offers both injectable and oral (tablet) compounded semaglutide, and requires no insurance.

What Roboclinic costs

The lowest rates require a 12-month plan: semaglutide from $179/month and tirzepatide from $299/month. Month-to-month runs $299/month (semaglutide) to $399/month (tirzepatide) — a real step-up from the 12-month rate.

The brand-vs-compounded question

Roboclinic dispenses compounded semaglutide and tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Roboclinic's real strengths is an all-in price bundling the provider consult, prescription, and delivery, same-price-every-dose pricing, an oral option alongside injections, and fulfillment routed through OpenLoop Health, a real clinical infrastructure partner. The trade-offs: the lowest rates require a 12-month plan — month-to-month costs meaningfully more, individual compounding pharmacies aren't named, no published per-state list — the site claims "all 50 states, restrictions apply" and gates doctor review by region, refunds are limited to your most recent billing cycle with none for used or partially used periods, and it's operated by a newer brand (BrickFi, Inc.) with limited independent track record. As with any GLP-1 program, and especially one with a limited refund window, confirm your state's actual coverage during intake; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Roboclinic's same-price-every-dose structure and OpenLoop clinical infrastructure are real positives, but the lowest rate requires a 12-month commitment, and refunds are limited to your most recent billing cycle. For a provider with month-to-month flexibility at a similarly flat rate, compare it against Ondra Health or Rebody Health. See our best tirzepatide providers ranking for the full field.